Overnight Digest- Stocks to look out for on November 4

DSIJ Intelligence / 03 Nov 2016

Overnight Digest- Stocks to look out for on November 4

The stocks which could witness significant movement on November 4 are ITC, Tiger Logistics/Blue dart/ Sical Logistics, Berger Paints, Monsanto and Dr Lal Path Labs.

The stocks which could witness significant movement on November 4 are ITC, Tiger Logistics/Blue dart/ Sical Logistics, Berger Paints, Monsanto and Dr Lal Path Labs.

ITC :- The stock will be reacting to the GST rate that may be finalised at 40 per cent for tobacco products. The sin goods will be attracting higher taxes.

Tiger Logistics /Blue dart/Sical Logistics :- With the GST rate expected to be finalised in the GST council meet, the logistics companies will be in the limelight.

Berger Paints :-  The company came up with its quarterly results and the total income declared was up by 7.8 percent with the EBITDA up by 17.3 per cent. The Company has posted a net profit of Rs. 1613.20 million for the quarter ended September 30, 2016 as compared to Rs. 762.70 million for the quarter ended September 30, 2015. 

Monsanto :-  Reports net profits  of Rs 0.9 crore vs loss of Rs 26 crore with improvement in EBITDA margins. The company has declared Rs 15 per share dividends.

Dr Lal Path Lab: - The company has declared its Q2 results with profits rising 8-fold and margins expanding 30.4 per cent.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.